<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03100695</url>
  </required_header>
  <id_info>
    <org_study_id>226136</org_study_id>
    <nct_id>NCT03100695</nct_id>
  </id_info>
  <brief_title>Tibial Fracture - Platelet-rich Plasma and Bone Marrow Concentrate</brief_title>
  <acronym>T-PAC</acronym>
  <official_title>A Prospective, Randomised, Single-centre Feasibility Study of Combined Autologous Platelet-rich Plasma and Concentrated Autologous Bone Marrow in Adult Patients With a Fresh Unilateral Tibial Diaphyseal Fracture Treated With Either Fine Wire Ring Fixator Device (Ilizarov) or Reamed Intramedullary Nailing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leeds</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leeds</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, randomised study is to investigate the feasibility of conducting a superiority&#xD;
      randomised controlled trial comparing the application of combined autologous PRP and&#xD;
      concentrated autologous bone marrow (PRP-BMA) in addition to standard of care (either reamed&#xD;
      intramedullary nailing or fine wire ring external fixator) for patients presenting with fresh&#xD;
      tibial diaphyseal fractures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 4, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to healing</measure>
    <time_frame>2 weeks, 8 weeks, 12 weeks,16 weeks, 20 weeks, 26 weeks, 39 weeks</time_frame>
    <description>Healing will be assessed both clinically and radiologically (RUST score)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Unilateral Tibial Diaphyseal Fracture</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will undergo operative procedure with no additional intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo usual operative procedure with the addition of an injection of autologous, concentrated PRP-BMA at the site of fixation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Concentrated autologous PRP-BMA</intervention_name>
    <description>Injection of autologous, concentrated platelet-rich plasma and bone marrow aspirate at the site of fixation.</description>
    <arm_group_label>Study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18-65, skeletally mature adults.&#xD;
&#xD;
          -  Acute unilateral closed tibia diaphyseal fractures as the primary injury.&#xD;
&#xD;
          -  Definitive fracture fixation with reamed intramedullary nailing (statically locked) or&#xD;
             fine wire ring external fixator to be performed within 14 days from the date of&#xD;
             injury.&#xD;
&#xD;
          -  Willing and able (in the opinion of the study team) to provide informed consent and&#xD;
             participate in all study activities.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Open/compound tibial fracture.&#xD;
&#xD;
          -  Fracture Type 42-C2 according to Muller AO classification.&#xD;
&#xD;
          -  Multi-segmental nature of this fracture (more than one fracture site within tibia for&#xD;
             intervention.)&#xD;
&#xD;
          -  Polytrauma (defined as injury severity score of 17 or more.)&#xD;
&#xD;
          -  Prior or concomitant illnesses that may affect healing.&#xD;
&#xD;
          -  Exposure to drugs that can affect the bone metabolic state within the past three&#xD;
             months.&#xD;
&#xD;
          -  Receiving chemotherapy, radiation treatment or immunosuppression drugs.&#xD;
&#xD;
          -  Currently enrolled in any other study which may impact on the results of the present&#xD;
             study.&#xD;
&#xD;
          -  If female: pregnancy, breast-feeding, not currently using and not willing to use an&#xD;
             effective form of contraception for 12 months post-surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 20, 2017</study_first_submitted>
  <study_first_submitted_qc>March 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leeds</investigator_affiliation>
    <investigator_full_name>PeterGiannoudis</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

